Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-26

Clinical Trial Update: A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing arfolitixorin with leucovorin in combination with FOLFOX and bevacizumab for advanced colorectal cancer has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Arfolitixorin (arfolitixorin)
  • Bevacizumab (bevacizumab)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Isofol Medical AB | Conditions: Colo-rectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-10-26